307 related articles for article (PubMed ID: 1374600)
1. Therapeutic approaches to hemoglobin switching in treatment of hemoglobinopathies.
Stamatoyannopoulos JA; Nienhuis AW
Annu Rev Med; 1992; 43():497-521. PubMed ID: 1374600
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological induction of fetal hemoglobin: Why haven't we been more successful in thalassemia?
Fathallah H; Sutton M; Atweh GF
Ann N Y Acad Sci; 2005; 1054():228-37. PubMed ID: 16339670
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic induction of fetal hemoglobin synthesis: cellular and molecular mechanisms.
Yang YM; Pace B
Pediatr Pathol Mol Med; 2001; 20(1):87-106. PubMed ID: 12673846
[TBL] [Abstract][Full Text] [Related]
4. Induction of hemoglobin F synthesis in patients with beta thalassemia.
Ley TJ; Nienhuis AW
Annu Rev Med; 1985; 36():485-98. PubMed ID: 2581500
[TBL] [Abstract][Full Text] [Related]
5. DNA hypomethylation therapy for hemoglobin disorders: molecular mechanisms and clinical applications.
Fathallah H; Atweh GF
Blood Rev; 2006 Jul; 20(4):227-34. PubMed ID: 16513230
[TBL] [Abstract][Full Text] [Related]
6. Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease.
Rodgers GP; Dover GJ; Uyesaka N; Noguchi CT; Schechter AN; Nienhuis AW
N Engl J Med; 1993 Jan; 328(2):73-80. PubMed ID: 7677965
[TBL] [Abstract][Full Text] [Related]
7. Fetal hemoglobin chemical inducers for treatment of hemoglobinopathies.
Testa U
Ann Hematol; 2009 Jun; 88(6):505-28. PubMed ID: 19011856
[TBL] [Abstract][Full Text] [Related]
8. Future prospects for treatment of hemoglobinopathies.
Stamatoyannopoulos JA
West J Med; 1992 Dec; 157(6):631-6. PubMed ID: 1282285
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic manipulation of fetal hemoglobin levels in sickle cell diseases and thalassemia: promise and reality.
Pearson HA
Adv Pediatr; 1996; 43():309-34. PubMed ID: 8794181
[No Abstract] [Full Text] [Related]
10. Molecular biology of hemoglobin: its application to sickle cell anemia and thalassemia.
Kan YW
Schweiz Med Wochenschr Suppl; 1991; 43():51-4. PubMed ID: 1726857
[TBL] [Abstract][Full Text] [Related]
11. Delta beta thalassemia and hereditary persistence of fetal hemoglobin.
Bollekens JA; Forget BG
Hematol Oncol Clin North Am; 1991 Jun; 5(3):399-422. PubMed ID: 1713909
[TBL] [Abstract][Full Text] [Related]
12. KLF10 gene expression is associated with high fetal hemoglobin levels and with response to hydroxyurea treatment in β-hemoglobinopathy patients.
Borg J; Phylactides M; Bartsakoulia M; Tafrali C; Lederer C; Felice AE; Papachatzopoulou A; Kourakli A; Stavrou EF; Christou S; Hou J; Karkabouna S; Lappa-Manakou C; Ozgur Z; van Ijcken W; von Lindern M; Grosveld FG; Georgitsi M; Kleanthous M; Philipsen S; Patrinos GP
Pharmacogenomics; 2012 Oct; 13(13):1487-500. PubMed ID: 23057549
[TBL] [Abstract][Full Text] [Related]
13. [Fetal hemoglobin].
Rokicka-Piotrowicz M
Postepy Hig Med Dosw; 1989; 43(5-6):475-97. PubMed ID: 2484927
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic manipulation of fetal hemoglobin synthesis.
Dover GJ; Humphries RK; Young N; Ley T; Boyer S; Charache S; Nienhuis A
Prog Clin Biol Res; 1985; 191():447-54. PubMed ID: 2413480
[TBL] [Abstract][Full Text] [Related]
15. Disorders of the synthesis of human fetal hemoglobin.
Manca L; Masala B
IUBMB Life; 2008 Feb; 60(2):94-111. PubMed ID: 18379999
[TBL] [Abstract][Full Text] [Related]
16. A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders.
Perrine SP; Ginder GD; Faller DV; Dover GH; Ikuta T; Witkowska HE; Cai SP; Vichinsky EP; Olivieri NF
N Engl J Med; 1993 Jan; 328(2):81-6. PubMed ID: 7677966
[TBL] [Abstract][Full Text] [Related]
17. Induction of fetal hemoglobin in the treatment of sickle cell disease.
Fathallah H; Atweh GF
Hematology Am Soc Hematol Educ Program; 2006; ():58-62. PubMed ID: 17124041
[TBL] [Abstract][Full Text] [Related]
18. Fetal hemoglobin levels in adults.
Rochette J; Craig JE; Thein SL
Blood Rev; 1994 Dec; 8(4):213-24. PubMed ID: 7534152
[TBL] [Abstract][Full Text] [Related]
19. Concordant fetal hemoglobin response to hydroxyurea in siblings with sickle cell disease.
Steinberg MH; Voskaridou E; Kutlar A; Loukopoulos D; Koshy M; Ballas SK; Castro O; Barton F
Am J Hematol; 2003 Feb; 72(2):121-6. PubMed ID: 12555216
[TBL] [Abstract][Full Text] [Related]
20. Impact of epigenetic mechanisms on therapeutic approaches of hemoglobinopathies.
Costa D; Capuano M; Sommese L; Napoli C
Blood Cells Mol Dis; 2015 Aug; 55(2):95-100. PubMed ID: 26142322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
